Vmbook Online ordering

Propell Technologies Group In

Propell Technologies Group Inc. (formerly known as Healthengine.com, Inc.) is a development stage company focused on the marketing, sale and distribution of proprietary products and solutions for the refrigerated and bulk transport industries. The company, through its Zeta Therapeutic Systems division, offers a line of cryogenic delivery systems, which includes the VitriVault and CryoPak product lines, for the storage and transportation of cells, tissue, blood and other biological materials. These systems utilize liquid nitrogen or liquid carbon dioxide in the preservation process.

The company does not have any revenues and has been incurring net losses. For the fiscal year ended December 31, 2020, the company reported a net loss of approximately $3.4 million, compared to a net loss of approximately $2.5 million for the fiscal year ended December 31, 2019. As of December 31, 2020, the company had an accumulated deficit of approximately $72.8 million.

The company's stock is currently listed on the OTC Markets Group's OTCQB marketplace under the symbol "PROP." The company's market capitalization as of February 16, 2022 is around $1.8 million.

It's important to note that the information provided here is based on the company's most recent financial statements and may not be up-to-date. Also, investing in small-cap stocks, especially in development stage company, carries a high degree of risk and it's highly speculative. It's recommended to consult a financial advisor or conduct your own research before making any investment decisions.